- Lupin Limited is a pharmaceutical company.
- They focus on non-steroidal anti-inflammatory drugs, bacterial infections and cardiovascular disease.
- They are 2nd largest pharma company by market capitalization in India.
- Headquartered in Mumbai the company is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs for the developed and developing markets of the world.
- There products reach over 100 countries in the world.
- Lupin has emerged as the 5th largest and the fastest growing Top 5 company in the U.S (by prescriptions) the only Asian company to achive this feet.
- One can invest in this strong multibagger for a minimum target of 1550 in 2yrs timeframe.
Annual Results:
Mar ' 13 | Mar ' 12 | Mar ' 11 | Mar ' 10 | Mar ' 09 | |
Sales | 7123 | 5385 | 4509 | 3709 | 2967 |
Operating profit | 1884 | 1162 | 973 | 815 | 575 |
Interest | 33 | 29 | 26 | 28 | 42 |
Gross profit | 1874 | 1137 | 950 | 790 | 538 |
EPS (Rs) | 28.16 | 18.01 | 18.15 | 14.59 | 10.07 |
No comments:
Post a Comment